Description
Global Over-the-Counter (OTC) Drug Markets
Global Over-the-Counter (OTC) Drug Markets discusses the world and regional OTC markets, including information on the following: world OTC drug market revenues: 2017 to 2023; top twenty OTC drug markets, country market share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, rest of world); and world OTC drug market revenues, markets by product segment, 2017 to 2023 (central nervous system, dermatological, gastrointestinal, respiratory, other, total). The coverage of regional OTC markets in the report goes to the country level in North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.
Kalorama Information divides and discusses OTC product markets in five general segments: OTC central nervous system agents (analgesics, anti-inflammatories, and other central nervous system agents), OTC dermatological agents (acne treatments, antifungals/antiinfectives, hair growth remedies, others), OTC gastrointestinal system agents (laxatives, antacids, antidiarrheals, H2 antagonists, proton pump inhibitors), OTC respiratory system agents (antihistamines, decongestants, cough preparations, other respiratory agents), and OTC agents – various therapeutic classifications (smoking cessation market, contraceptive drugs, weight management drugs [OTC drugs, not dietary supplements], overactive bladder treatments).
Global OTC Drug Markets notes the leading suppliers’ shares of the OTC drug market by revenues for 2017 and also includes in-depth profiles of market competitors such as Bayer, Johnson & Johnson, Pfizer, Procter & Gamble, and Sanofi.
